CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
59.72
0.90 (1.53%)
At close: Aug 15, 2025, 3:59 PM
59.96
0.40%
After-hours: Aug 15, 2025, 07:57 PM EDT
CRISPR Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 892K | 865K | 35M | 602K | 517K | 504K | 200M | n/a | 70M | 100M | 6K | 94K | 158K | 178K | 12.35M | 329K | 900.2M | 202K |
Cost of Revenue | 49.75M | 57.51M | n/a | 11.15M | 56.98M | 51.8M | 20M | 23.42M | 44.64M | 42.19M | 6.82M | 38.86M | 33.92M | 30.65M | 134.92M | 22.46M | 26.95M | 19.95M |
Gross Profit | -48.86M | -56.64M | 35M | -10.55M | -56.46M | -51.3M | 180M | -23.42M | 25.36M | 57.81M | -6.82M | -38.77M | -33.76M | -30.47M | -122.57M | -22.14M | 873.26M | -19.74M |
Operating Income | -133.07M | -148.42M | -64.59M | -110.13M | -151.26M | -140.59M | 69.58M | -132.41M | -95.22M | -64.49M | -131.54M | -182.39M | -183.26M | -175.97M | -145.7M | -128.85M | 762.62M | -114.54M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20.67M | 18.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -207.26M | -134.89M | -36.61M | -85.07M | -125.12M | -115.87M | 89.58M | -111.74M | -76.82M | -51.74M | -120.05M | -175.12M | -179.72M | -175.61M | -143.5M | -127.75M | 763.37M | -112.59M |
Net Income | -208.55M | -136M | -37.31M | -85.94M | -126.41M | -116.59M | 89.35M | -112.15M | -77.74M | -53.06M | -110.58M | -174.55M | -185.83M | -179.22M | -141.25M | -127.15M | 759.23M | -113.16M |
Selling & General & Admin | 18.92M | 19.3M | 18.12M | 17.42M | 19.48M | 17.95M | 16.48M | 18.29M | 19.03M | 22.36M | 21.17M | 27M | 26.27M | 28.02M | 24.13M | 24.35M | 29.81M | 24.52M |
Research & Development | 65.29M | 72.48M | 77.31M | 82.16M | 75.32M | 71.34M | 95.14M | 90.7M | 101.56M | 99.94M | 103.56M | 116.62M | 123.22M | 118.25M | 134.47M | 105.32M | 108.28M | 90.56M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 20M | n/a | n/a | n/a | n/a | n/a | n/a | -762K | 2.2M | 1.1M | 750K | 1.96M |
Operating Expenses | 84.21M | 91.78M | 99.59M | 99.58M | 94.8M | 89.29M | 110.42M | 108.99M | 120.59M | 122.3M | 124.72M | 143.62M | 149.5M | 145.5M | 158.05M | 129.18M | 137.58M | 114.75M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 133.96M | 149.29M | 99.59M | 110.73M | 151.78M | 141.09M | 130.42M | 132.41M | 165.22M | 164.49M | 131.55M | 182.48M | 183.42M | 176.15M | 158.05M | 129.18M | 137.58M | 114.75M |
Income Tax Expense | 1.29M | 1.11M | 700K | 876K | 1.29M | 724K | 233K | -412K | 923K | 1.32M | -9.48M | -575K | 6.12M | 3.61M | -2.25M | -595K | 4.14M | 575K |
Shares Outstanding (Basic) | 87.07M | 85.94M | 85.46M | 85.23M | 84.92M | 81.79M | 79.69M | 79.41M | 79.09M | 78.68M | 78.34M | 77.92M | 77.43M | 77.1M | 76.65M | 76.14M | 75.83M | 74.94M |
Shares Outstanding (Diluted) | 87.07M | 85.94M | 85.46M | 85.23M | 84.92M | 81.79M | 81.32M | 79.41M | 79.09M | 78.68M | 78.34M | 78.02M | 77.51M | 77.1M | 76.65M | 76.29M | 80.45M | 75.01M |
EPS (Basic) | -2.4 | -1.58 | -0.44 | -1.01 | -1.49 | -1.43 | 1.12 | -1.41 | -0.98 | -0.67 | -1.41 | -2.24 | -2.4 | -2.32 | -1.84 | -1.67 | 10.01 | -1.51 |
EPS (Diluted) | -2.4 | -1.58 | -0.44 | -1.01 | -1.49 | -1.43 | 1.10 | -1.41 | -0.98 | -0.67 | -1.41 | -2.24 | -2.4 | -2.32 | -1.84 | -1.67 | 9.44 | -1.51 |
EBITDA | -202.66M | -143.69M | -59.75M | -105.39M | -146.41M | -135.75M | 74.48M | -127.49M | -90.26M | -59.44M | -125.69M | -177.37M | -175.99M | -169.93M | -139.44M | -123.53M | 766.27M | -111.83M |
EBIT | -207.26M | -148.42M | -36.61M | -110.13M | -151.26M | -140.59M | 89.58M | -132.41M | -95.22M | -64.49M | -131.54M | -182.39M | -183.26M | -175.97M | -145.7M | -128.85M | 763.37M | -114.54M |
Depreciation & Amortization | 4.6M | 4.74M | 4.84M | 4.8M | 4.84M | 4.83M | 4.9M | 4.92M | 4.96M | 5.05M | 5.85M | 5.02M | 7.27M | 6.04M | 6.26M | 5.32M | 3.65M | 2.71M |